Board Meeting-Outcome of Committee Meeting
The Allotment Committee of the Board of Directors of the Company at its meeting held today i.e. on Wednesday, February 14, 2018, allotted 13,834 (Thirteen Thousand Eight Hundred and Thirty Four) equity shares of Re. 1/- each, on exercise of stock options under the SUN Employee Stock Option Scheme - 2015. Results - Financial Results For Q3 FY18
Please find enclosed herewith our Press Release relating to third quarter & nine month FY18 financials, Thanking you, Outcome Of The Board Meeting Held On February 14, 2018
Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held on today i.e. Wednesday, February 14, 2018, duly approved the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended December 31, 2017, which are enclosed herewith alongwith the... Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Valia Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Valia Updates
Sub: News Clarification - Sun Pharmaceutical Industries Limited With reference to your email dated February 5, 2018, for clarification on media report appearing in Money Control dated February 05, 2018, titled 'Fire at Sun Pharma's Ankleshwar plant, company says no casualties', we hereby submit our response as follows: A fire was observed at the solvent storage area at the Company's Ankleshwar (Gujarat) Plant in the early hours of Feb... Clarification sought from Sun Pharmaceutical Industries Ltd
The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd with respect to news article appearing on www.moneycontrol.com - February 5, 2018 titled "Fire at Sun Pharma's Ankleshwar plant, company says no casualties".The reply is awaited. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pratham Investments Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jayant S Sanghvi Press Release / Media Release
We are pleased to enclose herewith our Press Release relating to announcement of financial results for the third quarter & nine month ending December 31, 2017, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you,